Current Asset is all of company's assets that can be used to pay off current liabilities within current fiscal period or over next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.
Current Asset is important to company's creditors and private equity firms as they will often be interested in how much that company has in current assets, since these assets can be easily liquidated in case the company goes bankrupt. However it is usually not enough to know if a company is in a good shape just based on current asset alone; the amount of current liabilities should always be considered.
In accordance with recently published financial statements Nabi Biopharmaceuticals has Current Asset of 92.95 M. This is much higher than that of sector, and significantly higher than that of Current Asset industry, The Current Asset for all stocks is over 1000% lower than the firm.
Filter other Stocks by Current Asset
Nabi is currently under evaluation in current asset category among related companies.
Follow Nabi Current Asset with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Other Nabi Fundamentals